94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Ana Tajuelo1†
Octavio Carretero2†
Estéfani García-Ríos3,4
Mireia López-Siles1Olga Cano5Mónica Vázquez5Vicente Más5Isabel Rodríguez-Goncer2
Antonio Lalueza6,7Francisco López-Medrano2,7,8Rafael San Juan2,7,8
Mario Fernández-Ruiz2,7,8
José M. Aguado2,7,8
Michael J. McConnell1‡
Pilar Pérez-Romero3*‡- 1Intrahospital Infections Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III (ISCIII), Madrid, Spain
- 2Unit of Infectious Diseases, Hospital Universitario “12 de Octubre”, Instituto de Investigación Sanitaria Hospital “12 de Octubre” (imas12), Madrid, Spain
- 3Infecciones Víricas e Inmunidad en Enfermos Inmunodeprimidos, National Centre for Microbiology, Instituto de Salud Carlos III (ISCIII), Madrid, Spain
- 4Universidad Internacional de Valencia-VIU, Valencia, Spain
- 5Biología Viral, National Centre for Microbiology, Instituto de Salud Carlos III (ISCIII), Madrid, Spain
- 6Department of Internal Medicine, Hospital Universitario “12 de Octubre”, Instituto de Investigación Sanitaria Hospital “12 de Octubre” (imas12), Madrid, Spain
- 7Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain
- 8Department of Medicine, Universidad Complutense, Madrid, Spain
by Tajuelo A, Carretero O, García-Ríos E, López-Siles M, Cano O, Vázquez M, Más V, Rodríguez-Goncer I, Lalueza A, López-Medrano F, San Juan R, Fernández-Ruiz M, Aguado JM, McConnell MJ and Pérez-Romero P (2022) Front. Immunol. 13:878812. doi: 10.3389/fimmu.2022.878812
In the published article, the initials for an author in the article citation were incorrectly spelt as “Juan RS”. The correct spelling is “San Juan R”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: SARS-CoV-2, COVID disease severity, humoral response, IgG, IgM 2
Citation: Tajuelo A, Carretero O, García-Ríos E, López-Siles M, Cano O, Vázquez M, Más V, Rodríguez-Goncer I, Lalueza A, López-Medrano F, San Juan R, Fernández-Ruiz M, Aguado JM, McConnell MJ and Pérez-Romero P (2022) Corrigendum: Brief Research Report: Virus-Specific Humoral Immunity at Admission Predicts the Development of Respiratory Failure in Unvaccinated SARS-CoV-2 Patients. Front. Immunol. 13:965809. doi: 10.3389/fimmu.2022.965809
Received: 10 June 2022; Accepted: 13 June 2022;
Published: 30 June 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Tajuelo, Carretero, García-Ríos, López-Siles, Cano, Vázquez, Más, Rodríguez-Goncer, Lalueza, López-Medrano, San Juan, Fernández-Ruiz, Aguado, McConnell and Pérez-Romero. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Pilar Pérez-Romero, bXBwZXJlekBpc2NpaWkuZXM=
†These authors share the first authorship
‡These authors contributed equally to this work and sharethe last authorship